Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Bullboard - Stock Discussion Forum WPD Pharmaceuticals Inc WPDPF

Primary Symbol: C.WBIO

Industrials Technology

WPD Pharmaceuticals Inc. is a Canada-based clinical-stage pharmaceutical company, with a focus on glioblastoma cancer (GBM) and other brain tumor programs. The Company is a biotechnology research and development company with a focus on oncology, namely research and development of medicinal products involving biological compounds and small molecules. It has four novel drug candidates with one in... see more

Add To Watchlist

CSE:WBIO - Post Discussion

WPD Pharmaceuticals Inc > Prepayment of $705,000

View:

Post by etcetera on Sep 16, 2020 7:48am

Prepayment of $705,000

WPD Pharmaceuticals Receives Second Prepayment of $705,000 from Total $7.4 Million Grant for Development of WPD101

VANCOUVER, British Columbia, Sept. 16, 2020 (GLOBE NEWSWIRE) --

WPD Pharmaceuticals Inc. (CSE: WBIO)(FSE: 8SV1) (the “Company” or
“WPD”) a clinical-stage pharmaceutical company, is pleased to announce
that it has received a prepayment of approximately C$705,000 (2,000,000
PLN) and approval for reimbursement of approximately C$175,000
(500,000 PLN) from the Polish National Center for Research and Development (“NCRD”) granted by the European Union, under the Smart Growth Operational Program 2014-2020, for the further development of WPD101, the Company’s drug candidate targeting glioblastoma (“GBM”) which includes Phase I clinical studies.

more at :

https://www.globenewswire.com/news-release/2020/09/16/2094419/0/en/WPD-Pharmaceuticals-Receives-Second-Prepayment-of-705-000-from-Total-7-4-Million-Grant-for-Development-of-WPD101.html

175